Imidex VisiRad XR Receives FDA Clearance
Imidex announced that it has received FDA 510(k) clearance for its flagship VisiRad XR product that uses AI to look for lung cancer.
Imidex announced that it has received FDA 510(k) clearance for its flagship VisiRad XR product that uses AI to look for lung cancer.
Imidex announced that it has received FDA 510(k) clearance for its flagship VisiRad XR product that uses AI to look for lung cancer.